$HELE
HELEN OF TROY LTD Stock $hele

$hele Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000091678924000030 Filed on July 09, 2024

Income Statement

Concept	2024 Q2
Revenue	$416.8M
YoY Change	-12.18%
Cost Of Revenue	$213.8M
YoY Change	-17.48%
Gross Profit	$203.1M
YoY Change	-5.82%
Gross Profit Margin	48.72%
Selling, General & Admin	$170.5M
YoY Change	6.37%
% of Gross Profit	83.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.84M
YoY Change	29.13%
% of Gross Profit	6.81%
Operating Expenses	$170.5M
YoY Change	3.36%
Operating Profit	$30.76M
YoY Change	-39.32%
Interest Expense	-$12.54M
YoY Change	-10.74%
% of Operating Profit	-40.77%
Other Income/Expense, Net	$100.0K
YoY Change	-27.01%
Pretax Income	$18.32M
YoY Change	-31.45%
Income Tax	$12.12M
% Of Pretax Income	66.14%
Net Earnings	$6.204M
YoY Change	-72.53%
Net Earnings / Revenue	1.49%
Basic Earnings Per Share	$0.26
Diluted Earnings Per Share	$0.26
COMMON SHARES
Basic Shares Outstanding	23.81M shares
Diluted Shares Outstanding	23.63M shares

Balance Sheet

Concept	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.15M
YoY Change	-58.46%
Cash & Equivalents	$16.15M
Short-Term Investments
Other Short-Term Assets	$30.59M
YoY Change	25.07%
Inventory	$444.7M
Prepaid Expenses
Receivables	$328.1M
Other Receivables	$11.98M
Total Short-Term Assets	$831.6M
YoY Change	-2.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$334.4M
YoY Change	-14.59%
Goodwill	$1.067B
YoY Change	0.0%
Intangibles	$532.4M
YoY Change	-3.09%
Long-Term Investments
YoY Change
Other Assets	$15.20M
YoY Change	66.81%
Total Long-Term Assets	$1.989B
YoY Change	-1.36%
TOTAL ASSETS
Total Short-Term Assets	$831.6M
Total Long-Term Assets	$1.989B
Total Assets	$2.821B
YoY Change	-1.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$245.2M
YoY Change	8.41%
Accrued Expenses	$163.6M
YoY Change	18.45%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$7.031M
YoY Change	12.77%
Total Short-Term Liabilities	$427.7M
YoY Change	-2.98%
LONG-TERM LIABILITIES
Long-Term Debt	$741.3M
YoY Change	-10.78%
Other Long-Term Liabilities	$12.15M
YoY Change	-78.07%
Total Long-Term Liabilities	$753.5M
YoY Change	-14.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$427.7M
Total Long-Term Liabilities	$753.5M
Total Liabilities	$1.271B
YoY Change	-6.37%
SHAREHOLDERS EQUITY
Retained Earnings	$1.194B
YoY Change	0.63%
Common Stock	$352.5M
YoY Change	7.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.550B
YoY Change
Total Liabilities & Shareholders Equity	$2.821B
YoY Change	-1.81%

Cashflow Statement

Concept	2024 Q2
OPERATING ACTIVITIES
Net Income	$6.204M
YoY Change	-72.53%
Depreciation, Depletion And Amortization	$13.84M
YoY Change	29.13%
Cash From Operating Activities	$25.32M
YoY Change	-79.08%
INVESTING ACTIVITIES
Capital Expenditures	$9.142M
YoY Change	-23.03%
Acquisitions
YoY Change
Other Investing Activities	-$19.00K
YoY Change	-107.72%
Cash From Investing Activities	-$9.161M
YoY Change	-21.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$1.563M
YoY Change	0.0%
Cash From Financing Activities	-$18.51M
YoY Change	-81.42%
NET CHANGE
Cash From Operating Activities	$25.32M
Cash From Investing Activities	-$9.161M
Cash From Financing Activities	-$18.51M
Net Change In Cash	-$2.353M
YoY Change	-124.02%
FREE CASH FLOW
Cash From Operating Activities	$25.32M
Capital Expenditures	$9.142M
Free Cash Flow	$16.18M
YoY Change	-85.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	167635000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	213768000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	259041000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	100000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	203079000	usd
CY2024Q2	us-gaap	Restructuring Charges RestructuringCharges	1835000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	215631000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12116000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	170481000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4145000	usd
CY2023Q2	us-gaap	Restructuring Charges RestructuringCharges	7355000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	30763000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	137000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	40641000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23524000	shares
CY2024Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	6204000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18320000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	26726000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.94
CY2023Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	22581000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24049000	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23633000	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.94
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	6204000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-227000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2168000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	22581000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10715000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	308000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2338000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3389000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	9297000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9796000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29073000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16148000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38869000	usd
CY2023Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2579000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	6204000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	319000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2878000	usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	88000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	5833000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	29000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	12543000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	14052000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24134000	shares
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-3092000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-623000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	698000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	246000	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4446000	usd
CY2023Q2	hele	Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect	9297000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1514908000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1637442000	usd
CY2024Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	6204000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	698000	usd
CY2024Q2	hele	Stock Issued During Period Value Stock Options Exercised Net Of Tax Effect StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxEffect	352000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2006000	usd
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	103035000	usd
CY2024Q2	hele	Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect	5833000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1549500000	usd
CY2024Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	10445000	usd
CY2023Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3897000	usd
CY2024Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-64595000	usd
CY2024Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	48754000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-21572000	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3565000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1420000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-327000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	656000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2350000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	246000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	12543000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	14052000	usd
CY2024Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	6204000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	698000	usd
CY2024Q2	hele	Stock Issued During Period Value Stock Options Exercised Net Of Tax Effect StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxEffect	352000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2006000	usd
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	103035000	usd
CY2024Q2	hele	Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect	5833000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	6204000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13836000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	319000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2878000	usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	88000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	29000	usd
CY2024Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-64595000	usd
CY2023Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-26733000	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3565000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1420000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	656000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2350000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	36644000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10734000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-9742000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-3362000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	25320000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	121056000	usd
CY2024Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	9142000	usd
CY2023Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11877000	usd
CY2024Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	683000	usd
CY2023Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
CY2024Q2	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	626000	usd
CY2023Q2	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	usd
CY2024Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	38000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9161000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11631000	usd
CY2024Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	314040000	usd
CY2023Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	70150000	usd
CY2024Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	230090000	usd
CY2023Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	166150000	usd
CY2024Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1563000	usd
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1563000	usd
CY2024Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	222000	usd
CY2023Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2023Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-26733000	usd
CY2024Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	48754000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-21572000	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3565000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1420000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-327000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	656000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2350000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	36644000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	12543000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	14052000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	925000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-19465000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3715000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10734000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-9742000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18866000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-3362000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1488811000	usd
CY2023Q2	hele	Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect	9297000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1514908000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1637442000	usd
CY2024Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	6204000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	698000	usd
CY2024Q2	hele	Stock Issued During Period Value Stock Options Exercised Net Of Tax Effect StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxEffect	352000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2006000	usd
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	103035000	usd
CY2024Q2	hele	Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect	5833000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1549500000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	6204000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13836000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2878000	usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	88000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	5833000	usd
CY2023Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3897000	usd
CY2024Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-64595000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	25320000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	121056000	usd
CY2024Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	9142000	usd
CY2023Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11877000	usd
CY2024Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	683000	usd
CY2023Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
CY2024Q2	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	626000	usd
CY2024Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	38000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	246000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11631000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	319000	usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	88000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	5833000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	29000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	246000	usd
CY2024Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-64595000	usd
CY2023Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-26733000	usd
CY2024Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	48754000	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3565000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1420000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	12543000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	14052000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	22581000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6902000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-327000	usd
CY2023Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	22581000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	656000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3715000	usd
CY2023Q2	hele	Stock Issued During Period Value Stock Options Exercised Net Of Tax Effect StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxEffect	212000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2350000	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4446000	usd
CY2023Q2	hele	Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect	9297000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1514908000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1637442000	usd
CY2024Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	6204000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2006000	usd
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	103035000	usd
CY2024Q2	hele	Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect	5833000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1549500000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	6204000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13836000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	36644000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-19465000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10734000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-9742000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-3362000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	25320000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	121056000	usd
CY2024Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	9142000	usd
CY2023Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11877000	usd
CY2024Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	683000	usd
CY2023Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
CY2024Q2	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	626000	usd
CY2023Q2	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	usd
CY2024Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	38000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-19465000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10734000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-9742000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-3362000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	25320000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	121056000	usd
CY2024Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	9142000	usd
CY2023Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11877000	usd
CY2024Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	683000	usd
CY2023Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
CY2023Q2	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	usd
CY2024Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	38000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11631000	usd
CY2024Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	314040000	usd
CY2023Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	70150000	usd
CY2024Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	230090000	usd
CY2024Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1563000	usd
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1563000	usd
CY2024Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	222000	usd
CY2023Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2023Q2	hele	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options And Tax Benefits ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAndTaxBenefits	2380000	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	103035000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18501000	usd
CY2024Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5647000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2024Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	246000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9161000	usd
CY2024Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	314040000	usd
CY2023Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	70150000	usd
CY2024Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	230090000	usd
CY2023Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	166150000	usd
CY2024Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1563000	usd
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1563000	usd
CY2024Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	222000	usd
CY2023Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	103035000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4446000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18512000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-99629000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18501000	usd
CY2024Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5647000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2024Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17620000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	36572000	usd
CY2024Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	40485000	usd
CY2024Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	37851000	usd
CY2024Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	19335000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	21282000	usd
CY2024Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	314040000	usd
CY2023Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	70150000	usd
CY2024Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	230090000	usd
CY2023Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	166150000	usd
CY2024Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1563000	usd
CY2024Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	222000	usd
CY2023Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2024Q2	hele	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options And Tax Benefits ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAndTaxBenefits	2358000	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	103035000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18512000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2353000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18501000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2024Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17620000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	36572000	usd
CY2024Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	40485000	usd
CY2024Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	37851000	usd
CY2024Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	19335000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	21282000	usd
CY2024Q2	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	27179000	usd
CY2024Q1	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	29212000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	58942000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	163561000	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	103035000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2353000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18501000	usd
CY2024Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5647000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2024Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17620000	usd
CY2024Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	40485000	usd
CY2024Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	37851000	usd
CY2024Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	19335000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	21282000	usd
CY2024Q2	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	27179000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	58942000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	56474000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	163561000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	181391000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17620000	usd
CY2024Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	40485000	usd
CY2024Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	37851000	usd
CY2024Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	19335000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	21282000	usd
CY2024Q2	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	27179000	usd
CY2024Q1	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	29212000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	163561000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	181391000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	5569000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	8656000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2024Q2	hele	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Target Achievement As A Percentage ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTargetAchievementAsAPercentage	0
CY2021Q3	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	usd
CY2021Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	245400000	usd
CY2024Q2	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	27179000	usd
CY2024Q1	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	29212000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	163561000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	181391000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	5569000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2021Q3	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	usd
CY2021Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	245400000	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5960000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6279000	usd
CY2024Q2	hele	Long Term Debt Less Unamortized Prepaid Financing Fees LongTermDebtLessUnamortizedPrepaidFinancingFees	748377000	usd
CY2024Q1	hele	Long Term Debt Less Unamortized Prepaid Financing Fees LongTermDebtLessUnamortizedPrepaidFinancingFees	665671000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	7031000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	6250000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	741346000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	659421000	usd
CY2024Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	12500000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	181391000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	5569000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	8656000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2024Q2	hele	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Target Achievement As A Percentage ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTargetAchievementAsAPercentage	0
CY2021Q3	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	usd
CY2021Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	245400000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6279000	usd
CY2024Q2	hele	Long Term Debt Less Unamortized Prepaid Financing Fees LongTermDebtLessUnamortizedPrepaidFinancingFees	748377000	usd
CY2024Q1	hele	Long Term Debt Less Unamortized Prepaid Financing Fees LongTermDebtLessUnamortizedPrepaidFinancingFees	665671000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	7031000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	741346000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	659421000	usd
CY2024Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	12500000	usd
CY2024Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2023Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	14900000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	5569000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	8656000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2021Q3	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	usd
CY2021Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	245400000	usd
CY2021Q4	hele	Loss Contingency Number Of Other Defendants LossContingencyNumberOfOtherDefendants	5	renewal
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5960000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6279000	usd
CY2024Q2	hele	Long Term Debt Less Unamortized Prepaid Financing Fees LongTermDebtLessUnamortizedPrepaidFinancingFees	748377000	usd
CY2024Q1	hele	Long Term Debt Less Unamortized Prepaid Financing Fees LongTermDebtLessUnamortizedPrepaidFinancingFees	665671000	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5960000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6279000	usd
CY2024Q2	hele	Long Term Debt Less Unamortized Prepaid Financing Fees LongTermDebtLessUnamortizedPrepaidFinancingFees	748377000	usd
CY2024Q1	hele	Long Term Debt Less Unamortized Prepaid Financing Fees LongTermDebtLessUnamortizedPrepaidFinancingFees	665671000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	7031000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	6250000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	741346000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	659421000	usd
CY2024Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	12500000	usd
CY2024Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2023Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	14900000	usd
CY2024Q1	hele	Debt Instrument Restrictive Covenant Maximum Net Leverage Ratio DebtInstrumentRestrictiveCovenantMaximumNetLeverageRatio	3.25
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1268000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1745000	usd
CY2024Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	22000	usd
CY2023Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-24000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-3101000	usd
CY2023Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	1745000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	-1131000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3715000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	2184000	usd
CY2024Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	1268000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	218000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	416847000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	474672000	usd
CY2023Q2	hele	Income Tax Expense Benefit Percentage Of Income Before Income Taxes IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes	0.155
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	7031000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	6250000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	741346000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	659421000	usd
CY2024Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	12500000	usd
CY2024Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2023Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	14900000	usd
CY2023Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	900000	usd
CY2024Q1	hele	Debt Instrument Restrictive Covenant Maximum Net Leverage Ratio DebtInstrumentRestrictiveCovenantMaximumNetLeverageRatio	3.25
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-3101000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1268000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1745000	usd
CY2024Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	22000	usd
CY2023Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-24000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-3101000	usd
CY2023Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	1745000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	-1131000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3715000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	2184000	usd
CY2024Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	1268000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	218000	usd
CY2024Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2023Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	14900000	usd
CY2023Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	900000	usd
CY2024Q1	hele	Debt Instrument Restrictive Covenant Maximum Net Leverage Ratio DebtInstrumentRestrictiveCovenantMaximumNetLeverageRatio	3.25
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-3101000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1268000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1745000	usd
CY2024Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	22000	usd
CY2023Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-24000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-3101000	usd
CY2023Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	1745000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	-1131000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3715000	usd
CY2024Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	1268000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	218000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	416847000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	474672000	usd
CY2024Q2	hele	Income Tax Expense Benefit Percentage Of Income Before Income Taxes IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes	0.661
CY2023Q2	hele	Income Tax Expense Benefit Percentage Of Income Before Income Taxes IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes	0.155
CY2023Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	900000	usd
CY2024Q1	hele	Debt Instrument Restrictive Covenant Maximum Net Leverage Ratio DebtInstrumentRestrictiveCovenantMaximumNetLeverageRatio	3.25
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	2184000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-3101000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1268000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1745000	usd
CY2024Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	22000	usd
CY2023Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-24000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-3101000	usd
CY2023Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	1745000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	-1131000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3715000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	218000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	698000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	416847000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	474672000	usd
CY2023Q2	hele	Income Tax Expense Benefit Percentage Of Income Before Income Taxes IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes	0.155
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23524000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24049000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	109000	shares
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	698000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	416847000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	474672000	usd
CY2024Q2	hele	Income Tax Expense Benefit Percentage Of Income Before Income Taxes IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes	0.661
CY2023Q2	hele	Income Tax Expense Benefit Percentage Of Income Before Income Taxes IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes	0.155
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23524000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24049000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	109000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	85000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23633000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24134000	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23524000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24049000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	109000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	85000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23633000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24134000	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24049000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	109000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	85000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23633000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24134000	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	85000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23633000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24134000	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0000916789-24-000030-index-headers.html	Edgar Link	pending
0000916789-24-000030-index.html	Edgar Link	pending
0000916789-24-000030.txt	Edgar Link	pending
0000916789-24-000030-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fy25_q1xexhibit311.htm	Edgar Link	pending
fy25_q1xexhibit312.htm	Edgar Link	pending
fy25_q1xexhibit32.htm	Edgar Link	pending
hele-20240531.htm	Edgar Link	pending
hele-20240531.xsd	Edgar Link	pending
hele-20240531_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
hele-20240531_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
hele-20240531_def.xml	Edgar Link	unprocessable
hele-20240531_lab.xml	Edgar Link	unprocessable
hele-20240531_pre.xml	Edgar Link	unprocessable
hele-20240531_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
0000916789-24-000030-index-headers.html	Edgar Link	pending
0000916789-24-000030-index.html	Edgar Link	pending
0000916789-24-000030.txt	Edgar Link	pending
0000916789-24-000030-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fy25_q1xexhibit311.htm	Edgar Link	pending
fy25_q1xexhibit312.htm	Edgar Link	pending
fy25_q1xexhibit32.htm	Edgar Link	pending
hele-20240531.htm	Edgar Link	pending
hele-20240531.xsd	Edgar Link	pending
hele-20240531_g1.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hele-20240531_cal.xml	Edgar Link	unprocessable
hele-20240531_def.xml	Edgar Link	unprocessable
hele-20240531_lab.xml	Edgar Link	unprocessable
hele-20240531_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
hele-20240531_pre.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HELE
HELEN OF TROY LTD Stock $hele

2024 Q2 Form 10-Q Financial Statement

#000091678924000030 Filed on July 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HELE HELEN OF TROY LTD Stock $hele

2024 Q2 Form 10-Q Financial Statement

#000091678924000030 Filed on July 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HELE
HELEN OF TROY LTD Stock $hele